Abstract:Parkinson's disease (PD) is among the most prevalent neurodegenerative disorders, affecting over 10 million people worldwide. The protein encoded by the SNCA gene, alpha‐synuclein (ASYN), is the major component of Lewy body (LB) aggregates, a histopathological hallmark of PD. Mutations and posttranslational modifications (PTMs) in ASYN are known to influence protein aggregation and LB formation, possibly playing a crucial role in PD pathogenesis. In this work, we applied computational methods to characterize the effects of missense mutations and PTMs on the structure and function of ASYN. Missense mutations in ASYN were compiled from the literature/databases and underwent a comprehensive predictive analysis. Phosphorylation and SUMOylation sites of ASYN were retrieved from databases and predicted by algorithms. ConSurf was used to estimate the evolutionary conservation of ASYN amino acids. Molecular dynamics (MD) simulations of ASYN wild‐type and variants A30G, A30P, A53T, and G51D were performed using the GROMACS package. Seventy‐seven missense mutations in ASYN were compiled. Although most mutations were not predicted to affect ASYN stability, aggregation propensity, amyloid formation, and chaperone binding, the analyzed mutations received relatively high rates of deleterious predictions and predominantly occurred at evolutionarily conserved sites within the protein. Moreover, our predictive analyses suggested that the following mutations may be possibly harmful to ASYN and, consequently, potential targets for future investigation: K6N, T22I, K34E, G36R, G36S, V37F, L38P, G41D, and K102E. The MD analyses pointed to remarkable flexibility and essential dynamics alterations at nearly all domains of the studied variants, which could lead to impaired contact between NAC and the C‐terminal domain triggering protein aggregation. These alterations may have functional implications for ASYN and provide important insight into the molecular mechanism of PD, supporting the design of future biomedical research and improvements in existing therapies for the disease.

E46K-like α-synuclein mutants increase lipid interactions and disrupt membrane selectivity

Parkinson's disease-associated mutations in α-synuclein alters its lipid-bound state

Parkinson’s disease associated mutation E46K of α-synuclein triggers the formation of a novel fibril structure

E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease

In silico analysis of alpha‐synuclein protein variants and posttranslational modifications related to Parkinson's disease

3,4‐Dihydroxyphenylethanol and 3,4‐dihydroxyphenylacetic acid affect the aggregation process of E46K variant of α‐synuclein at different extent: Insights into the interplay between protein dynamics and catechol effect

α-Synuclein Oligomers Displace Monomeric α-Synuclein from Lipid Membranes

α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson's disease

Parkinson's disease associated mutation E46K of -synuclein triggers the formation of a distinct fibril structure

The Role of Alpha Synuclein in Synucleinopathy: Impact on Lipid Regulation at Mitochondria ER Membranes

Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies

Abnormal accumulation of lipid droplets in neurons induces the conversion of alpha-Synuclein to proteolytic resistant forms in a Drosophila model of Parkinson's disease

Elucidating the mechanisms of α-Synuclein-lipid interactions using site-directed mutagenesis

β-synuclein regulates the phase transitions and amyloid conversion of α-synuclein

High expression levels of the D686N Parkinson's disease mutation in VPS35 induces α-synuclein-dependent toxicity in yeast

Synj1 Haploinsufficiency Causes Dopamine Neuron Vulnerability and Alpha-Synuclein Accumulation in Mice

Intercellular transfer of pathogenic α-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal

α-Synuclein acts as a cholesteryl-ester sensor on lipid droplets regulating organelle size and abundance.

Self-limiting multimerization of α-synuclein on membrane and its implication in Parkinson's diseases

Brain region-specific susceptibility of Lewy body pathology in synucleinopathies is governed by α-synuclein conformations